Neuronal pentraxin 1 Hypoxic-ischemic brain injury Oxygen glucose deprivation Mitochondria Bax Bad Developing brain is highly susceptible to hypoxic-ischemic (HI) injury leading to severe neurological disabilities in surviving infants and children. Previously, we have reported induction of neuronal pentraxin 1 (NP1), a novel neuronal protein of long-pentraxin family, following HI neuronal injury. Here, we investigated how this specific signal is propagated to cause the HI neuronal death. We used wild-type (WT) and NP1 knockout (NP1-KO) mouse hippocampal cultures, modeled in vitro following exposure to oxygen glucose deprivation (OGD), and in vivo neonatal (P9-10) mouse model of HI brain injury. Our results show induction of NP1 in primary hippocampal neurons following OGD exposure (4-8 h) and in the ipsilateral hippocampal CA1 and CA3 regions at 24-48 h post-HI compared to the contralateral side. We also found increased PTEN activity concurrent with OGD time-dependent (4-8 h) dephosphorylation of Akt (Ser473) and GSK-3β (Ser9). OGD also caused a time-dependent decrease in the phosphorylation of Bad (Ser136), and Bax protein levels. Immunofluorescence staining and subcellular fractionation analyses revealed increased mitochondrial translocation of Bad and Bax proteins from cytoplasm following OGD (4 h) and simultaneously increased release of Cyt C from mitochondria followed by activation of caspase-3. NP1 protein was immunoprecipitated with Bad and Bax proteins; OGD caused increased interactions of NP1 with Bad and Bax, thereby, facilitating their mitochondrial translocation and dissipation of mitochondrial membrane potential (ΔΨ m ). This NP1 induction preceded the increased mitochondrial release of cytochrome C (Cyt C) into the cytosol, activation of caspase-3 and OGD time-dependent cell death in WT primary hippocampal neurons. In contrast, in NP1-KO neurons there was no translocation of Bad and Bax from cytosol to the mitochondria, and no evidence of ΔΨ m loss, increased Cyt C release and caspase-3 activation following OGD; which resulted in significantly reduced neuronal death. Our results indicate a regulatory role of NP1 in Bad/Bax-dependent mitochondrial release of Cyt C and caspase-3 activation. Together our findings demonstrate a novel mechanism by which NP1 regulates mitochondria-driven hippocampal cell death; suggesting NP1 as a potential therapeutic target against HI brain injury in neonates.
Introduction
Brain injury due to fetal or neonatal asphyxia (Johnston, 1997; Lorenz et al., 1998; Northington et al., 2001a Northington et al., , 2001b or neonatal stroke is a leading cause of morbidity and mortality in surviving infants and children worldwide with a high societal cost (Balduini et al., 2004; Gresham et al., 1997; Shiber et al., 2010; Sudlow and Warlow, 1997; Volpe, 2001) , and has an incidence as high as 1 in 4000 (Ferriero, 2004; Nelson, 2007) . Yet, there is no promising therapy for neonatal brain injury at present; very few trials have documented limited clinical benefit (Blomgren and Hagberg, 2006; Kalenderian et al., 2009; Pezzini and Padovani, 2009; Uchino et al., 2001 ), in part, owing to incomplete understanding of the pathological secondary injury mechanisms that proceed from the primary insult (Blomgren et al., 2003; Blomgren and Hagberg, 2006; Pezzini and Padovani, 2009; Smaha, 2004) . The hippocampus is often injured in neonatal stroke (Osredkar et al., 2010) , and that disruption of oxygen and glucose supply resulting from occlusion of a blood vessel ultimately leads to neuronal losses and necrosis (Banasiak et al., 2000) . Previously, we demonstrated the induction of a novel neuronal protein neuronal pentraxin 1 (NP1) in in vivo rat model of hypoxicischemic (HI) brain injury (Hossain et al., 2004) , and that NP1 induction in HI cortical neuronal cell death is regulated via a glycogen synthase kinase (GSK)-3α/β-dependent mechanism (Russell et al., 2011) . However, how this specific signal of NP1 induction is propagated to cause the HI neuronal death remains to be elucidated.
The cellular decision as to whether cells will undergo death or survival process is determined by the integration of multiple survival and death signals. The PI3-K/Akt signaling pathway plays a critical Neurobiology of Disease 50 (2013) 59-68 
